Terapi & Livskvalitet ApS — Credit Rating and Financial Key Figures
CVR number: 37124389
Gryti 15, Smørumnedre 2765 Smørum
mbp@kongevaenget.dk
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 33.31 | 30.43 | |||
| External services | -23.19 | -36.65 | -8.93 | ||
| Gross profit | -23.19 | -3.34 | 21.50 | -5.92 | 0.53 |
| EBIT | -23.19 | -3.34 | 21.50 | -5.92 | 0.53 |
| Other financial income | 259.92 | ||||
| Pre-tax profit | 236.73 | -3.34 | 21.50 | -5.92 | 0.53 |
| Net earnings | 236.73 | -3.34 | 21.50 | -5.92 | 0.53 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 11.06 | ||||
| Short term receivables total | 11.06 | ||||
| Cash and bank deposits | 0.64 | 1.68 | 12.12 | 1.00 | 1.53 |
| Cash and cash equivalents | 0.64 | 1.68 | 12.12 | 1.00 | 1.53 |
| Balance sheet total (assets) | 0.64 | 1.68 | 23.18 | 1.00 | 1.53 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | - 297.98 | -61.25 | -64.58 | -43.08 | -49.00 |
| Profit of the financial year | 236.73 | -3.34 | 21.50 | -5.92 | 0.53 |
| Shareholders equity total | -11.25 | -14.58 | 6.92 | 1.00 | 1.53 |
| Non-current liabilities total | |||||
| Current owed to group member | 16.26 | ||||
| Other non-interest bearing current liabilities | 11.88 | 16.26 | |||
| Current liabilities total | 11.88 | 16.26 | 16.26 | ||
| Balance sheet total (liabilities) | 0.64 | 1.68 | 23.18 | 1.00 | 1.53 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.